Safe and pragmatic use of sodium–glucose co-transporter 2 inhibitors in type 2 diabetes mellitus: South Asian Federation of Endocrine Societies consensus statement

Diabetes prevalence shows a continuous increasing trend in South Asia. Although well-established treatment modalities exist for type 2 diabetes mellitus (T2DM) management, they are limited by their side effect profile. Sodium–glucose co-transporter 2 inhibitors (SGLT2i) with their novel insulin-inde...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Indian J Endocrinol Metab
Main Authors: Kalra, Sanjay, Ghosh, Sujoy, Aamir, A. H., Ahmed, Md. Tofail, Amin, Mohammod Feroz, Bajaj, Sarita, Baruah, Manash P., Bulugahapitiya, Uditha, Das, A. K., Giri, Mimi, Gunatilake, Sonali, Mahar, Saeed A., Pathan, Md. Faruque, Qureshi, Nazmul Kabir, Raza, S. Abbas, Sahay, Rakesh, Shakya, Santosh, Shreshta, Dina, Somasundaram, Noel, Sumanatilleke, Manilka, Unnikrishnan, A. G., Wijesinghe, Achini Madushani
Format: Artigo
Sprog:Inglês
Udgivet: Medknow Publications & Media Pvt Ltd 2017
Fag:
Review Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5240067/
https://ncbi.nlm.nih.gov/pubmed/28217523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.196029
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker